Scotts Miracle-Gro Co

SMG

CIK 0000825542 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-27) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$354M
↓-3.3% -$12Mvs FY2024 (Q4)
Gross Profit
$89M
↑+0.2% +$187Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
61/100
  • Profitability
    43ROIC 13.5% (10% = solid, 20%+ = moat)
  • Liquidity
    39Current Ratio 1.27 (above 1.5 = solid)
  • Leverage
    100D/E -5.73 (under 0.5 = conservative)
  • Efficiency
    78Asset Turnover 1.22x (1.0+ = capital-efficient)
  • Growth
    6Revenue YoY -3.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -6.2% · trend +4.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project SMG's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$80.27
Total enterprise IV
$4.71B
Diluted shares
0.06B
Terminal PV
$3.42B (72% of total)
Year-5 FCF
$402M
YearProjected FCFDiscounted PV
+1$296M$269M
+2$319M$264M
+3$345M$259M
+4$373M$255M
+5$402M$250M
Terminal$5.50B$3.42B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$88M
investment in PP&E
Dividends paid (TTM)
$153M
cash returned to holders
Stock buybacks (TTM)
$11M
share count reduction
Stock-based comp (TTM)
$61M
non-cash dilution

Balance sheet · 2025-12-27

latest filed snapshot
Total assets
$3.03B
everything owned
Total liabilities
$3.53B
everything owed
Stockholders' equity
$-501M
shareholder claim
Net debt
$2.24B
LT debt minus cash

Recent performance · 67 quarters

Revenue↓-3.3% -$12M
$354M
Net Income↓-79.9% -$56M
$-125M
Free Cash Flow↑+17.7% +$84M
$-390M
Operating Margin↑+6.3pts
-6.2%

Drill down